Cenovus Energy (CVE) is down 6.9% today. Here is some analysis on what might have caused this price movement.
Analysis: The selloff looks primarily macro-driven: crude prices fell sharply after officials signaled tanker traffic through the Strait of Hormuz could resume, reducing the “war premium” that had been supporting upstream cash-flow expectations. With Cenovus highly levered to realized heavy-oil pricing, the stock often amplifies big down days in oil.
Details:
Sources:
Associated Press, Axios, TheStreet
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$CVE Hedge Fund Activity
We have seen 240 institutional investors add shares of $CVE stock to their portfolio, and 146 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL WORLD INVESTORS removed 43,508,576 shares (-27.9%) from their portfolio in Q4 2025, for an estimated $736,165,105
- CAPITAL RESEARCH GLOBAL INVESTORS added 17,730,542 shares (+16.6%) to their portfolio in Q4 2025, for an estimated $300,000,770
- HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND added 12,564,179 shares (+440.8%) to their portfolio in Q4 2025, for an estimated $212,585,908
- FIL LTD added 11,019,212 shares (+40.0%) to their portfolio in Q4 2025, for an estimated $186,445,067
- BOSTON PARTNERS removed 8,817,157 shares (-39.7%) from their portfolio in Q4 2025, for an estimated $149,186,296
- VANGUARD GROUP INC added 7,197,843 shares (+12.8%) to their portfolio in Q4 2025, for an estimated $121,787,503
- NATIONAL BANK OF CANADA /FI/ added 6,725,588 shares (+108.5%) to their portfolio in Q4 2025, for an estimated $113,796,948
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CVE Analyst Ratings
Wall Street analysts have issued reports on $CVE in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- RBC Capital issued a "Outperform" rating on 11/17/2025
- CIBC issued a "Outperformer" rating on 11/14/2025
To track analyst ratings and price targets for $CVE, check out Quiver Quantitative's $CVE forecast page.
$CVE Price Targets
Multiple analysts have issued price targets for $CVE recently. We have seen 5 analysts offer price targets for $CVE in the last 6 months, with a median target of $32.0.
Here are some recent targets:
- Manav Gupta from UBS set a target price of $41.0 on 04/09/2026
- Kevin Fisk from Scotiabank set a target price of $38.0 on 03/19/2026
- Neil Mehta from Goldman Sachs set a target price of $29.0 on 03/12/2026
- Greg Pardy from RBC Capital set a target price of $32.0 on 02/20/2026
- Dennis Fong from CIBC set a target price of $32.0 on 11/14/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.